New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Immunic, Inc.
IMUX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

86M

Biotechnology

Next Earning date - 27 Feb 2025

86M

Biotechnology

Next Earning date - 27 Feb 2025

0.96USD

Shape0.02 ( 1.99%)
Market Closed (as of Feb 14, 00:56 EDT)
favorite-chart

Relative Strenght

16
favorite-chart

Volume Buzz

-46%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

55%

Quote Panel

Shape
Updated February 14, 2025
1W -0.35 % 1M -5.28 % 3M -9.75 % 1Y -28.60 %

Key Metrics

Shape
  • Market Cap

    86.18M


  • Shares Outstanding

    90.08M


  • Share in Float

    87.36M


  • Dividende

    0


  • Earning Date

    27 Feb 2025


  • Price Target

    0.9567


  • Average Volume

    881860


  • Beta

    1.883


  • Range

    0.92-2.11


  • Industry

    Biotechnology


  • Website

    https://www.immunic-therapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

IMUX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$397M

ShapeNaN%

2025-Revenue

$0.77

Shape-219%

2025-EPS

0

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

EF Hutton

initialise

Previous: Not converted

2024-09-16

Now: Buy

B. Riley

initialise

Previous: Not converted

2024-08-27

Now: Buy

Brookline Capital

initialise

Previous: Not converted

2024-04-05

Now: Buy

SVB Leerink

downgrade

Previous: Not converted

2022-10-21

Now: Market Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-1.63
vs -0.81

Q1.23

arrow
arrow

N/A

-0.58
vs -0.74

Q2.23

arrow
arrow

N/A

-0.54
vs -0.72

Q3.23

arrow
arrow

N/A

-0.51
vs -0.69

Q4.23

arrow
arrow

N/A

-0.48
vs -1.63

Q1.24

arrow
arrow

N/A

-0.25
vs -0.58

Q2.24

arrow
arrow

N/A

-0.21
vs -0.54

Q3.24

arrow
arrow

N/A

-0.24
vs -0.51

Q4.24

arrow
arrow

N/A

-0.23
vs -0.48

Q1.25

arrow
arrow

N/A

-0.23
vs -0.25

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

NA

6K  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-78%

-0.78
vs -0.21

Q1.23

arrow
arrow

-26%

-0.26
vs -0.78

Q2.23

arrow
arrow

-35%

-0.35
vs -0.26

Q3.23

arrow
arrow

-47%

-0.47
vs -0.35

Q4.23

arrow
arrow

-75%

-0.75
vs -0.47

Q1.24

arrow
arrow

-35%

-0.35
vs -0.75

Q2.24

arrow
arrow

-34%

-0.34
vs -0.35

Q3.24

arrow
arrow

-59%

-0.59
vs -0.34

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

63

63
vs 69

-9%

Q2.23

arrow
arrow

68

68
vs 63

8%

Q3.23

arrow
arrow

56

56
vs 68

-18%

Q4.23

arrow
arrow

53

53
vs 56

-5%

Q1.24

arrow
arrow

63

63
vs 53

19%

Q2.24

arrow
arrow

60

60
vs 63

-5%

Q3.24

arrow
arrow

65

65
vs 60

8%

Q4.24

arrow
arrow

13

13
vs 65

-80%

Earnings Growth

Latest News